The total number of records retrieved from this search are 11. Click on ID to see further detail.

ID	Virus name	Virus strain	Virus genome type	Virus family	Virus genome modification	Virus alone	Virus in combination with drug/radiation	Immune gene insertion in viral genome	Source of cell line	Origin of cell line	Cell line	Concentration of cell line	In-vitro toxicity	Assay	In-vitro virus concentration	In-vitro result	Model organism	In-vivo virus concentration	In-vivo toxicity	In-vivo result	Mode of delivery	Pathway induced	Immunogenic effect	Clinical trial	PMID
IDOV_2769	Virus nameRespiratory synctial virus	Virus strainwild type	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineHuman skin cancer cell line	Cell lineA431	Concentration of cell line15E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration1 MOI	In-vitro resultModerate cell death after 24 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apotosis by virus in cancer cell line as measured by TUNEL assay	Immunogenic effectNA	Clinical trialNA	PMID23487261
IDOV_2770	Virus nameRespiratory synctial virus	Virus strainwild type	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineHuman skin cancer cell line	Cell lineA431	Concentration of cell line15E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration1 MOI	In-vitro resultModerate cell death after 36 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apotosis by virus in cancer cell line as measured by TUNEL assay	Immunogenic effectNA	Clinical trialNA	PMID23487261
IDOV_2771	Virus nameRespiratory synctial virus	Virus strainwild type	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineHuman skin cancer cell line	Cell lineA431	Concentration of cell line15E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration1 MOI	In-vitro resultMaximum cell death after 48 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apotosis by virus in cancer cell line as measured by TUNEL assay	Immunogenic effectNA	Clinical trialNA	PMID23487261
IDOV_2772	Virus nameRespiratory synctial virus	Virus strainwild type	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineHuman skin cancer cell line	Cell lineA431	Concentration of cell line15E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration3 MOI	In-vitro resultModerate cell death after 24 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apotosis by virus in cancer cell line as measured by TUNEL assay	Immunogenic effectNA	Clinical trialNA	PMID23487261
IDOV_2773	Virus nameRespiratory synctial virus	Virus strainwild type	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineHuman skin cancer cell line	Cell lineA431	Concentration of cell line15E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration3 MOI	In-vitro resultSignificant cell death after 36 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apotosis by virus in cancer cell line as measured by TUNEL assay	Immunogenic effectNA	Clinical trialNA	PMID23487261
IDOV_2774	Virus nameRespiratory synctial virus	Virus strainwild type	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineHuman skin cancer cell line	Cell lineA431	Concentration of cell line15E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration3 MOI	In-vitro resultMaximum cell death after 48 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apotosis by virus in cancer cell line as measured by TUNEL assay	Immunogenic effectNA	Clinical trialNA	PMID23487261
IDOV_4270	Virus nameMeasles virus	Virus strainrMV-SLAMblind	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationR533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineHuman nonsmall cell lung carcinoma cell line	Cell lineA431	Concentration of cell line5.0E+3 cells per well	In-vitro toxicityNA	AssayWST-1 assay	In-vitro virus concentration1 MOI	In-vitro result100% cell viability after day 1	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID26317644
IDOV_4271	Virus nameMeasles virus	Virus strainrMV-SLAMblind	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationR533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineHuman nonsmall cell lung carcinoma cell line	Cell lineA431	Concentration of cell line5.0E+3 cells per well	In-vitro toxicityNA	AssayWST-1 assay	In-vitro virus concentration1 MOI	In-vitro result100% cell viability after day 3	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID26317644
IDOV_4272	Virus nameMeasles virus	Virus strainrMV-SLAMblind	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationR533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineHuman nonsmall cell lung carcinoma cell line	Cell lineA431	Concentration of cell line5.0E+3 cells per well	In-vitro toxicityNA	AssayWST-1 assay	In-vitro virus concentration1 MOI	In-vitro result100% cell viability after day 5	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID26317644
IDOV_4273	Virus nameMeasles virus	Virus strainrMV-SLAMblind	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationR533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineHuman nonsmall cell lung carcinoma cell line	Cell lineA431	Concentration of cell line5.0E+3 cells per well	In-vitro toxicityNA	AssayWST-1 assay	In-vitro virus concentration1 MOI	In-vitro result80% cell viability after day 7	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID26317644
IDOV_5922	Virus nameMeasles virus	Virus strainwild type	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationMutated for SLAM binding	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineHuman lung cancer cell line	Cell lineA431	Concentration of cell lineNA	In-vitro toxicityNA	AssayWST-1 assay	In-vitro virus concentration1 MOI	In-vitro result20% cell killing after 7 days	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMIDUS10335481